1832 Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

1832 Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-99,800	Closed	-$15.3M	–	989
2021 Q4	$15.3M	Buy	99,800 +39,800	+66%	+$5.37M	0.03%	263
2021 Q3	$7.24M	Buy	+60,000	New	+$6.61M	0.01%	373
2020 Q4	–	Sell	-41,800	Closed	-$4.74M	–	747
2020 Q3	$4.74M	Buy	+41,800	New	+$4.39M	0.01%	333
2019 Q2	–	Sell	-148,100	Closed	-$9.29M	–	754
2019 Q1	$9.29M	Buy	+148,100	New	+$7.78M	0.03%	230

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

1832 Asset Management's TNDM Position: Q1 2022 in Review

1832 Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 99,800 shares — an estimated $15.3M sold.

1832 Asset Management first reported a position in TNDM in Q1 2019 and held it in 4 quarters. The position peaked at $15.3M in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

1832 Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
1832 Asset Management sold 99,800 Tandem Diabetes Care shares in Q1 2022, an estimated $15.3M.
1832 Asset Management first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 4 quarters.
1832 Asset Management's Tandem Diabetes Care position peaked at $15.3M in Q4 2021.
379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on 1832 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.